Louis Lehot Discusses M&A Trends and Concerns for 2025
January 3, 2025
Mergers & Acquisitions
Foley & Lardner LLP partner Louis Lehot shared perspective on the year ahead in the Mergers & Acquisitions article, “2025 M&A Outlook: Macro Concerns and Mega Trends.”
Asked what his major macroeconomic concerns are that will influence M&A activity in 2025, Lehot highlighted the power of the U.S. dollar.
“I am concerned that the dollar is not so strong that it makes our exports too expensive or encourages us to import too many goods that domestic onshoring of our manufacturing requirements is further stalled out,” he explained, “particularly in the area of advanced semiconductors.”
People
Related News
October 9, 2026
In the News
Jonathan Lasken Highlighted Across the Media for Arrival to Foley
Foley & Lardner LLP partner Jonathan Lasken is highlighted across the media for his recent arrival to the firm’s Washington D.C. office.
October 7, 2026
In the News
William Holtz Examines New FDA Approach to Clinical Trial Development
Foley & Lardner LLP of counsel William Holtz is quoted in the PharmaVoice article, “5 Key Facts About the FDA Expedited IND Pilot Program,” examining the FDA's new pilot program and its potential to accelerate clinical research.
October 5, 2026
In the News
Louis Lehot Analyzes U.S. IPO Market Trends and Outlook
Foley & Lardner LLP partner Louis Lehot is featured in the Daily Journal‘s Capital & Counsel newsletter offering insights on the current state of the U.S. IPO market and the factors influencing companies' routes to going public.